Business Context and Reporting Period
This Form 8-K Current Report was filed by The Clorox Company on May 18, 2011. The filing discloses a corporate action taken by the Board of Directors regarding capital allocation.
Key Financial Metrics
The filing does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The primary financial figure disclosed is the authorization of a new share repurchase program with an aggregate purchase amount of up to $750 million.
Material Changes
The material change reported is the authorization of a new $750 million share repurchase program. The filing notes that this new authorization will not be utilized until Fiscal Year 2012 at the earliest. Current repurchases continue under the May 13, 2008 authorization and an existing evergreen program designed to offset dilution from stock incentive plans.
Guidance, Outlook, and Risks
Management commentary indicates that repurchases under the new program will occur from time to time depending on market conditions. The Company explicitly states it has no obligation to repurchase shares under this authorization. The actual number and value of shares repurchased will depend on factors including share price. No specific risks, contingencies, or unusual items were detailed beyond the discretionary nature of the buyback.
Investor Verification Checklist
- Verify the total remaining authorization under the May 13, 2008 share repurchase program.
- Confirm the specific start date for the new $750 million program in Fiscal Year 2012.
- Review the terms of the existing evergreen repurchase program used to offset dilution.
- Monitor future filings for the first execution of shares under the new $750 million authorization.